Patient | Sex | Age | Position | Associated in situ carcinoma | Tumor size (cm) | Lymph node metastasis | Pathological stage | ER | PR | HER2 | Ki-67 | S-100 | Pan-TRK | Treatment | Follow-up (month) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Female | 39 | Left | No | 1.0 | 0 | T1N0M0 | Weak positive | negative | negative | 5% | positive | positive | mastectomy, LND, CT | 140m contralateral SBC |
 | Female | 51 | Right | No | 1.1 | 0 | T1N0M0 | Weak positive | negative | negative | 5% | positive | positive | mastectomy, LND, CT | 30m ANED |
2 | Female | 42 | Right | Yes | 4.0 | 2 | T2N1M0 | negative | negative | negative | 30% | positive | positive | mastectomy, LND, CT | 84m recurrence and distant metastasis |
 | Female | 49 | Chest wall | No | 2.5 | NA | - | negative | negative | negative | 35% | positive | positive | L,CT,RT, | 5m ANED |
3 | Female | 41 | Right | No | 2.0 | 0 | T1N0M0 | moderate to strong positive | negative | negative | 15% | positive | positive | L, LND, CT,RT, HT | 18m ANED |
4 | Female | 33 | Left | No | 7.0 | 0 | T2N0M0 | negative | negative | negative | 10% | positive | positive | L, LND | 10m ANED |
5 | Female | 39 | Left | No | 0.9 | 0 | T1N0M0 | negative | negative | negative | 20% | positive | positive | mastectomy, LND, | 8m ANED |